PLoS ONE · 2014 · 61 citations · 29 references
MedicineEndocrinologyOncologyCarcinogenesisGene ExpressionTranscriptional RegulationHepatocellular CarcinomaLiver CancerLiver DiseaseMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In Cancer3' Untranslated Region Analysis3' Untranslated Region RegulationMicrorna Function In CancerMicrorna Gene Transcriptional RegulationMicrorna Regulation In CancerReal-time Polymerase Chain Reaction (Pcr)
BACKGROUND & AIMS: Insulin-like growth factor, (IGF)-1, is produced mainly by the liver and plays important roles in promoting growth and regulating metabolism. Previous study reported that development of hepatocellular carcinoma (HCC) was accompanied by a significant reduction in serum IGF-1 levels. Here, we hypothesized that dysregulation of microRNAs (miRNA) in HCC can modulate IGF-1 expression post-transcriptionally. METHODS: The miRNAs expression profiles in a dataset of 29 HCC patients were examined using illumina BeadArray. Specific miRNA (miR)-190b, which was significantly up-regulated in HCC tumor tissues when compared with paired non-tumor tissues, was among those predicted to interact with 3'-untranslated region (UTR) of IGF-1. In order to explore the regulatory effects of miR-190b on IGF-1 expression, luciferase reporter assay, quantitative real-time PCR, western blotting and immunofluorecence analysis were performed in HCC cells. RESULTS: Overexpression of miR-190b in Huh7 cells attenuated the expression of IGF-1, whereas inhibition of miR-190b resulted in up-regulation of IGF-1. Restoration of IGF-1 expression reversed miR-190b-mediated impaired insulin signaling in Huh7 cells, supporting that IGF-1 was a direct and functional target of miR-190b. Additionally, low serum IGF-1 level was associated with insulin resistance and poor overall survival in HCC patients. CONCLUSIONS: Increased expression of miR-190 may cause decreased IGF-1 in HCC development. Insulin resistance appears to be a part of the physiopathologic significance of decreased IGF-1 levels in HCC progression. This study provides a novel miRNA-mediated regulatory mechanism for controlling IGF-1 expression in HCC and elucidates the biological relevance of this interaction in HCC.
29
Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart Disease
Anders Juul, Thomas Scheike, Michael Davidsen et al. · Circulation · 2002 · 641 citations · Full text
Medicine, Cardiology, Endocrinology +15
Fabrizio De Benedetti, Tonino Alonzi, Antonia Moretta et al. · Journal of Clinical Investigation · 1997 · 530 citations · Full text
Medicine, Endocrinology, Immunology +15
Liver-Specific <i>igf-1</i> Gene Deletion Leads to Muscle Insulin Insensitivity
Shoshana Yakar, Jun‐Li Liu, Ana M. Fernández et al. · Diabetes · 2001 · 350 citations · Full text
Wang Xh, R Qian, W Zhang et al. · Clinical and Experimental Pharmacology and Physiology · 2008 · 271 citations